Biopharma
Biotech Layoff Wave Hits Karyopharm, Century, and Pacira in 2025
biotech layoffs; Karyopharm Therapeutics; Century Therapeutics; Pacira; 2025 workforce reductions; biopharma restructuring
Biopharma Layoffs Continue to Surge in First Half of 2025
biopharma; layoffs; 2025; workforce reductions; industry trends; biotech closures; year-over-year increase
Trump Threatens 200% Tariffs on Pharma Imports, Proposes 1-Year Grace Period for Onshoring
Trump; pharmaceutical tariffs; 200% tariff; grace period; pharma manufacturing; drug imports; US supply chain; onshoring; policy; biopharma investments
Alphabet’s Calico Strikes $596M Deal for Mabwell’s Anti-Aging Antibody
Calico; Alphabet; Mabwell; anti-aging; biotech; IL-11 antibody; 9MW3811; exclusive licensing; aging-related diseases; biopharma deal
Over One-Third of Biotechs Face Cash Crunch, EY 2025 Report Finds
biotech; EY report; cash runway; life sciences; capital constraints; biopharma; 2025; macroeconomic uncertainty
May the (Power of the) Pool be with you: Accelerating time from DNA to GMP – STI-based CLD Platform
DNA to GMP; STI-based CLD Platform; bioprocessing; Endpoints News; webinar; cell line development; biopharma; time acceleration
Senate Drops Orphan Cures Act from Trump’s Tax Bill, Dealing Setback to Biopharma
Orphan Cures Act; orphan drugs; Trump tax bill; biopharma; Senate; IRA price negotiations; rare diseases; Big Beautiful Bill; healthcare legislation; reconciliation bill
FDA Launches New Priority Review Voucher Program Aligned with National Priorities
FDA; priority review voucher; CNPV; biopharma; drug approval; national priorities; accelerated review; unmet public health needs
New Rules and Regulatory Trends in Biopharma Manufacturing in 2025
biopharma manufacturing; 2025 regulations; FDA; digital quality systems; green manufacturing; import rules; Trump administration tariffs; country-of-origin labeling; forced labor compliance; serialization